Tislelizumab, paclitaxel, Carboplatin

DRUG2 trials

Sponsors

Sun Yat-sen University, Second Affiliated Hospital of Nanchang University

Conditions

Brain MetastasesNon-Small Cell Lung CancerNon-Small Cell Squamous Lung Cancer

Phase 2

Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases

Sun Yat-sen UniversityBrain Metastases, Non-Small Cell Squamous Lung Cancer

Start: 2021-06-17End: 2023-06-30Target: 41Updated: 2022-01-26

SFRT+Tislelizumab+Platinum Chemotherapy for Unresectable Stage III NSCLC

RecruitingNCT07131319

Second Affiliated Hospital of Nanchang UniversityNon-Small Cell Lung Cancer

Start: 2025-04-21End: 2028-12-31Target: 30Updated: 2026-06-25